BioSpace News Archive

Genetown

Solarea Bio Investigators Receive National Academy of Medicine Healthy Longevity 2022 Quickfire Challenge Award

Solarea Bio has been selected as an awardee of the NAM Healthy Longevity 2022 QuickFire Challenge, launched by Johnson & Johnson Innovation together with the National Academy of Medicine, for work studying the mycobiome as a novel class of probiotics to target inflammation associated with aging, or ‘inflammaging’.

September 29, 2022
·
4 min read
Pharm Country

Zoetis to Host Webcast and Conference Call on Third Quarter 2022 Financial Results

Zoetis Inc. (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, Nov. 3, 2022.

September 29, 2022
·
1 min read
Business

SP Industries Appoints Kevin Sutherby as New President

SP Industries, Inc, a leading global provider of fill-finish drug manufacturing solutions, lyophilizers, and laboratory equipment and supplies, has announced the appointment of Kevin Sutherby as its new President.

September 29, 2022
·
2 min read
Biotech Beach

City of Hope to Accelerate Immunotherapy Research and Treatment Innovation With $15 Million Gift From Ted Schwartz Family

City of Hope announced a $15 million gift from City of Hope patient and cancer survivor Ted Schwartz that will be used entirely to further accelerate immunotherapy research and treatment innovations, such as the chimeric antigen receptor T cell therapy that saved his life.

September 29, 2022
·
6 min read
Increasing Number Of Clinical Trials Ongoing To Avail Newer And Safer Treatment Options Is Expected To Drive Bronchial Spasm Treatment Market Growth By 2030 | Reports And Data

The latest market analysis report published by Reports and Data, titled ‘Global Bronchial Spasm Treatment Market – Forecast to 2030,’ thoroughly examines the Bronchial Spasm Treatment industry to provide essential data & information for the targeted readers.

September 29, 2022
·
6 min read
Increasing Prevalence Rate Of Eye Disease Is Expected To Drive Corneal Ulcer Treatment Market Growth By 2030 | Reports And Data

The latest market analysis report published by Reports and Data, titled ‘Global Corneal Ulcer Treatment Market – Forecast to 2030,’ thoroughly examines the Corneal Ulcer Treatment industry to provide essential data & information for the targeted readers.

September 29, 2022
·
6 min read
Rising Patient Numbers, And Increase In Public Knowledge Of The Infection Are Expected To Drive Pseudomonas Aeruginosa Infection Treatment Market Growth By 2030 | Reports And Data

The latest market analysis report published by Reports and Data, titled ‘Global Pseudomonas Aeruginosa Infection Treatment Market – Forecast to 2030’ thoroughly examines the Pseudomonas Aeruginosa Infection Treatment Market industry to provide essential data & information for the targeted readers

September 29, 2022
·
6 min read
Business

AffyImmune Therapeutics Adds Serial Entrepreneur Robert Forrester to Board of Directors

AffyImmune Therapeutics, Inc., a clinical stage biotechnology company using its Tune & Track platform to develop CAR T cells for the treatment of solid cancers, announced today that serial biotech entrepreneur Robert Forrester has been appointed to its Board of Directors.

September 29, 2022
·
3 min read
Drug Development

Alzamend Neuro Submits IND Application for Phase I/IIA Trial for an Immunotherapy (ALZN002) to Treat Mild to Moderate Dementia of the Alzheimer’s Type

Alzamend Neuro, Inc. today announced that it submitted an investigational new drug (“IND”) application to the U.S. Food and Drug Administration (“FDA”) for its immunotherapy product candidate ALZN002.

September 29, 2022
·
6 min read
Pharm Country

Integra LifeSciences Publishes Its Inaugural ESG Report

Integra LifeSciences Holdings Corporation, a leading global medical technology company, issued its inaugural Environmental, Social and Governance report.

September 29, 2022
·
3 min read